CTOs on the Move

Harvest Technologies Corporation

www.harvesttech.com

 
Harvest Technologies Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Plymouth, MA. To find more information about Harvest Technologies Corporation, please visit www.harvesttech.com
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Hanger

Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger, Inc. (NYSE: HGR) delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hanger`s Patient Care segment is the largest owner and operator of O&P patient care clinics with in excess of 730 locations nationwide. Through its Products and Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides therapeutic solutions. Steeped in over 150 years of clinical excellence and innovation, Hanger`s vision is to be the partner of choice for products and services that enhance human physical capability. Hanger helps those with limb loss, paralysis, and other physical challenges become productive members of society after injury or illness. Headquartered in Austin, TX and with locations in 45 states, our employees provide personal independence, increased mobility, and restored functionality.

BC Mental Health and Addiction Services

BC Mental Health and Addiction Services is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fox Chase

At Fox Chase Cancer Center, defeating cancer is our calling. Fox Chase is one of the nation`s first dedicated cancer hospitals, and our researchers and physicians have made major contributions to scientific advancement since our establishment more than a century ago in 1904. Fox Chase scientists have made breakthroughs in cancer prevention, diagnosis, treatment, and survivorship, and have earned the highest awards in their fields, including two Nobel Prizes. We translate these pioneering discoveries into world-class clinical care every day - with a single purpose: to defeat cancer and help the people it impacts. This calling is rooted in our cancer-specific, multidisciplinary teams of doctors, researchers, practitioners, and five-time Magnet designated nurses, who are all more than specialists in cancer; they are international experts in distinct types of cancer, whose deep and focused expertise provides the best chance for the best outcome anywhere along the cancer continuum. And they`re helping to advance the way cancer treatment is delivered around the world. The way we work together, with this single, shared passion for our patients` well-being, is what makes us truly unique.

Cayuga Medical Center

Cayuga Medical Center is a 204-bed, state-of-the art regional medical center. The Medical Center’s mission is to deliver the highest quality health care and is affiliated with many prestigious health care organizations including Cornell University's Weill Medical College in New York City, Roswell Park Cancer Institute in Buffalo, NY, Rochester General Hospital’s Heart Institute and the Mayo Medical Laboratories. CMC received a silver award for “The Center Is You” campaign that rolled out in 2008.  

Furiex

Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.